Annamaria Salvati

Salerno, 84131, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Correction: Suppression of Spry1 reduces HIF1α‑dependent glycolysis and impairs angiogenesis in BRAF‑mutant cutaneous melanoma.

Correction: Suppression of Spry1 reduces HIF1α‑dependent glycolysis and impairs angiogenesis in BRAF‑mutant cutaneous melanoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 21, 2026

Editorial: Chromatin modifications and gene expression: from mechanisms to therapeutic implications in disease.

Editorial: Chromatin modifications and gene expression: from mechanisms to therapeutic implications in disease.

Journal: Frontiers in genetics

Published: March 21, 2026

Epigenetic alterations of AKT1 orchestrate a metabolic reprogramming in advanced lipedema: translational insights from an integrated multi-omics study.

Epigenetic alterations of AKT1 orchestrate a metabolic reprogramming in advanced lipedema: translational insights from an integrated multi-omics study.

Journal: Journal of translational medicine

Published: November 03, 2025

Identification of LncRNAs scaffolding a chromatin-associated gene regulatory complex in breast cancer cells comprising ERα, DOT1L and menin.

Identification of LncRNAs scaffolding a chromatin-associated gene regulatory complex in breast cancer cells comprising ERα, DOT1L and menin.

Journal: Cell communication and signaling : CCS

Published: September 03, 2025

Castalin Induces ROS Production, Leading to DNA Damage and Increasing the Activity of CHK1 Inhibitor in Cancer Cell Lines.

Castalin Induces ROS Production, Leading to DNA Damage and Increasing the Activity of CHK1 Inhibitor in Cancer Cell Lines.

Journal: Antioxidants (Basel, Switzerland)

Published: August 03, 2025

Pharmacological Advances in Managing Exercise-Induced Bronchospasm: An Umbrella Review Following PRIOR Guideline.

Pharmacological Advances in Managing Exercise-Induced Bronchospasm: An Umbrella Review Following PRIOR Guideline.

Journal: Scandinavian journal of medicine & science in sports

Published: July 14, 2025

Non-coding RNA profiling in BRAFV600E-mutant cutaneous melanoma before and after Spry1 depletion.

Non-coding RNA profiling in BRAFV600E-mutant cutaneous melanoma before and after Spry1 depletion.

Journal: Scientific data

Published: June 13, 2025

Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies.

Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies.

Journal: Journal of translational medicine

Published: June 10, 2025

BRPF1 in cancer epigenetics: a key regulator of histone acetylation and a promising therapeutic target.

BRPF1 in cancer epigenetics: a key regulator of histone acetylation and a promising therapeutic target.

Journal: Cell death discovery

Published: June 03, 2025

Suppression of Spry1 reduces HIF1α-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma.

Suppression of Spry1 reduces HIF1α-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 02, 2024

LncRNA PVT1 links estrogen receptor alpha and the polycomb repressive complex 2 in suppression of pro-apoptotic genes in hormone-responsive breast cancer.

LncRNA PVT1 links estrogen receptor alpha and the polycomb repressive complex 2 in suppression of pro-apoptotic genes in hormone-responsive breast cancer.

Journal: Cell death & disease

Published: June 27, 2024

Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancers.

Essential gene screening identifies the bromodomain-containing protein BRPF1 as a new actionable target for endocrine therapy-resistant breast cancers.

Journal: Molecular cancer

Published: March 15, 2024

Showing 1-12 of 47

Last Updated: 09/26/2026